Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q60326756 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010847.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q60326756 | ||
| 024 | ‡a 0000-0003-2246-4378 ‡2 orcid | ||
| 024 | ‡a 6603458620 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q60326756 | ||
| 100 | 0 | ‡a Jose Angel Ruiz-Ortega ‡c researcher ORCID ID = 0000-0003-2246-4378 ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Jose Angel Ruiz-Ortega ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats | ||
| 670 | ‡a Author's Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors. | ||
| 670 | ‡a Author's Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats | ||
| 670 | ‡a Author's Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease | ||
| 670 | ‡a Author's Endocannabinoid modulation of dopaminergic motor circuits. | ||
| 670 | ‡a Author's Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. | ||
| 670 | ‡a Author's Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. | ||
| 670 | ‡a Author's In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease. | ||
| 670 | ‡a Author's Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease. | ||
| 670 | ‡a Author's Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo | ||
| 670 | ‡a Author's Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. | ||
| 670 | ‡a Author's Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation: a pharmacological and SPECT study. | ||
| 670 | ‡a Author's Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration. | ||
| 670 | ‡a Author's Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors. | ||
| 670 | ‡a Author's Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease. | ||
| 670 | ‡a Author's Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. | ||
| 670 | ‡a Author's Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors? | ||
| 670 | ‡a Author's Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. | ||
| 670 | ‡a Author's Stimulatory effect of harmane and other beta-carbolines on locus coeruleus neurons in anaesthetized rats. | ||
| 670 | ‡a Author's The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats | ||
| 670 | ‡a Author's The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated α2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis | ||
| 670 | ‡a Author's The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin | ||
| 670 | ‡a Author's Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. | ||
| 670 | ‡a Author's Two opposite effects of Delta(9)-tetrahydrocannabinol on subthalamic nucleus neuron activity: involvement of GABAergic and glutamatergic neurotransmission | ||
| 909 | ‡a (orcid) 0000000322464378 ‡9 1 | ||
| 909 | ‡a (scopus) 6603458620 ‡9 1 | ||
| 919 | ‡a stimulatoryeffectofharmaneandotherbetacarbolinesonlocuscoeruleusneuronsinanaesthetizedrats ‡A Stimulatory effect of harmane and other beta-carbolines on locus coeruleus neurons in anaesthetized rats. ‡9 1 | ||
| 919 | ‡a roleofthesubthalamicnucleusin50dopainduceddyskinesiain6hydroxydopaminelesionedrats ‡A The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats ‡9 1 | ||
| 919 | ‡a stimulatoryeffectofclonidineonlocuscoeruleusneuronsofratswithinactivatedα2adrenoceptorsinvolvementofimidazolinereceptorslocatedinthenucleusparagigantocellularis ‡A The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated α2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis ‡9 1 | ||
| 919 | ‡a 2oppositeeffectsofdelta9tetrahydrocannabinolonsubthalamicnucleusneuronactivityinvolvementofgabaergicandglutamatergicneurotransmission ‡A Two opposite effects of Delta(9)-tetrahydrocannabinol on subthalamic nucleus neuron activity: involvement of GABAergic and glutamatergic neurotransmission ‡9 1 | ||
| 919 | ‡a topographicaldistributionofmorphologicalchangesinapartialmodelofparkinsonsdiseaseeffectsofnanoencapsulatedneurotrophicfactorsadministration ‡A Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. ‡9 1 | ||
| 919 | ‡a buspironeantidyskineticeffectiscorrelatedwithtemporalnormalizationofdysregulatedstriataldrd1signallingin50dopatreatedrats ‡A Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats ‡9 1 | ||
| 919 | ‡a buspironerequirestheintactnigrostriatalpathwaytoreducetheactivityofthesubthalamicnucleusvia5ht1areceptors ‡A Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors. ‡9 1 | ||
| 919 | ‡a chronic50dopaadministrationincreasesthefiringratebutdoesnotreverseenhancedslowfrequencyoscillatoryactivityandsynchronizationinsubstantianigraparsreticulataneuronsfrom6hydroxydopaminelesionedrats ‡A Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats ‡9 1 | ||
| 919 | ‡a stimulatoryeffectofclonidinethroughimidazolinereceptorsonlocuscoeruleusnoradrenergicneuronesismediatedbyexcitatoryaminoacidsandmodulatedbyserotonin ‡A The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin ‡9 1 | ||
| 919 | ‡a deleteriouseffectsofvegfr2andretinhibitioninapreclinicalmodelofparkinsonsdisease ‡A Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease ‡9 1 | ||
| 919 | ‡a endocannabinoidmodulationofdopaminergicmotorcircuits ‡A Endocannabinoid modulation of dopaminergic motor circuits. ‡9 1 | ||
| 919 | ‡a excitatoryregulationofnoradrenergicneuronsby50argininenitricoxidepathwayintheratlocuscoeruleusinvivo ‡A Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. ‡9 1 | ||
| 919 | ‡a imidazolineinducedinhibitionoffiringrateof5htneuronsinratdorsalraphebymodulationofextracellular5htlevels ‡A Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. ‡9 1 | ||
| 919 | ‡a invivoadministrationofvegfandgdnfreleasingbiodegradablepolymericmicrospheresinaseverelesionmodelofparkinsonsdisease ‡A In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease. ‡9 1 | ||
| 919 | ‡a increasedantiparkinsonefficacyofthecombinedadministrationofvegfandgdnfloadednanospheresinapartiallesionmodelofparkinsonsdisease ‡A Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease. ‡9 1 | ||
| 919 | ‡a inhibitionof5hydroxytryptaminereuptakebytheantidepressantcitalopraminthelocuscoeruleusmodulatestheratbrainnoradrenergictransmissioninvivo ‡A Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo ‡9 1 | ||
| 919 | ‡a interactionbetweenthe5htsystemandthebasalgangliafunctionalimplicationandtherapeuticperspectiveinparkinsonsdisease ‡A Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. ‡9 1 | ||
| 919 | ‡a levodopainduceddyskinesiasinparkinsondiseaseareindependentoftheextentofstriataldopaminergicdenervationapharmacologicalandspectstudy ‡A Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation: a pharmacological and SPECT study. ‡9 1 | ||
| 919 | ‡a modulationofthesubthalamicnucleusactivitybyserotonergicagentsandfluoxetineadministration ‡A Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration. ‡9 1 | ||
| 919 | ‡a morphologicalchangesinaseveremodelofparkinsonsdiseaseanditssuitabilitytotestthetherapeuticeffectsofmicroencapsulatedneurotrophicfactors ‡A Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors. ‡9 1 | ||
| 919 | ‡a nanodeliveryofcerebrolysinandrearinginenrichedenvironmentinduceneuroprotectiveeffectsinapreclinicalratmodelofparkinsonsdisease ‡A Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease. ‡9 1 | ||
| 919 | ‡a nigrostriataldenervationchangestheeffectofcannabinoidsonsubthalamicneuronalactivityinrats ‡A Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. ‡9 1 | ||
| 919 | ‡a pharmacologicaltreatmentofparkinsonsdiseaselifebeyonddopamined2d3receptors ‡A Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors? ‡9 1 | ||
| 919 | ‡a preclinic Alpha rmacologyoff98214taanovelpotentserotoninandnorepinephrineuptakeinhibitorwithantidepressantandanxiolyticproperties ‡A Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 ISNI|0000000059820370 | ||
| 996 | ‡2 ISNI|0000000059388055 | ||
| 996 | ‡2 LC|n 79002118 | ||
| 996 | ‡2 NII|DA09416857 | ||
| 996 | ‡2 NTA|068600585 | ||
| 996 | ‡2 LC|n 2015211947 | ||
| 996 | ‡2 BNE|XX5101369 | ||
| 996 | ‡2 SUDOC|120698315 | ||
| 996 | ‡2 DNB|1057133000 | ||
| 996 | ‡2 BIBSYS|90699174 | ||
| 996 | ‡2 BNE|XX1150546 | ||
| 996 | ‡2 LC|no2010087992 | ||
| 996 | ‡2 LC|n 2009003941 | ||
| 996 | ‡2 LC|nr 94024630 | ||
| 996 | ‡2 J9U|987007368397305171 | ||
| 996 | ‡2 ICCU|CFIV000948 | ||
| 996 | ‡2 BNF|13494191 | ||
| 996 | ‡2 ISNI|0000000059560046 | ||
| 996 | ‡2 DNB|1057386766 | ||
| 996 | ‡2 LC|n 91108988 | ||
| 996 | ‡2 JPG|500227096 | ||
| 996 | ‡2 DNB|1056763337 | ||
| 996 | ‡2 LC|n 2016054519 | ||
| 996 | ‡2 ISNI|0000000061384547 | ||
| 996 | ‡2 BNE|XX1096741 | ||
| 996 | ‡2 NUKAT|n 2022182336 | ||
| 996 | ‡2 SUDOC|092075126 | ||
| 996 | ‡2 NKC|ntk2017957541 | ||
| 996 | ‡2 DNB|1057759031 | ||
| 996 | ‡2 DNB|1156965136 | ||
| 996 | ‡2 BNCHL|10000000000000000834086 | ||
| 996 | ‡2 LC|nr 93005299 | ||
| 996 | ‡2 BNC|981058512645306706 | ||
| 996 | ‡2 J9U|987007447018105171 | ||
| 996 | ‡2 LC|no2008182237 | ||
| 996 | ‡2 NII|DA11726620 | ||
| 996 | ‡2 NYNYRILM|128597 | ||
| 996 | ‡2 BNE|XX938352 | ||
| 996 | ‡2 SUDOC|200829394 | ||
| 996 | ‡2 LC|n 2013012599 | ||
| 996 | ‡2 BNF|15614801 | ||
| 996 | ‡2 SELIBR|297793 | ||
| 996 | ‡2 ISNI|0000000437091196 | ||
| 996 | ‡2 BNE|XX910213 | ||
| 996 | ‡2 LC|n 78091355 | ||
| 996 | ‡2 LC|nr2006004585 | ||
| 996 | ‡2 VLACC|000035091 | ||
| 996 | ‡2 BIBSYS|97038096 | ||
| 996 | ‡2 BNC|981058524006406706 | ||
| 996 | ‡2 BNE|XX1054953 | ||
| 996 | ‡2 BNE|XX954187 | ||
| 996 | ‡2 BNE|XX5553936 | ||
| 996 | ‡2 SUDOC|255347901 | ||
| 996 | ‡2 BNF|12783737 | ||
| 996 | ‡2 NII|DA13603042 | ||
| 996 | ‡2 ISNI|0000000120386359 | ||
| 996 | ‡2 SUDOC|180373218 | ||
| 996 | ‡2 ISNI|0000000356451268 | ||
| 996 | ‡2 PTBNP|1463463 | ||
| 996 | ‡2 SUDOC|237256819 | ||
| 996 | ‡2 BNC|981058516400306706 | ||
| 996 | ‡2 BNE|XX6409150 | ||
| 996 | ‡2 SUDOC|156502666 | ||
| 996 | ‡2 BNCHL|10000000000000000117740 | ||
| 996 | ‡2 NTA|079311296 | ||
| 996 | ‡2 ISNI|0000000083668778 | ||
| 996 | ‡2 BNE|XX6158507 | ||
| 996 | ‡2 LC|n 2024009700 | ||
| 996 | ‡2 BNC|981058528480206706 | ||
| 996 | ‡2 BNE|XX1188586 | ||
| 996 | ‡2 ISNI|0000000373462479 | ||
| 996 | ‡2 BAV|495_90878 | ||
| 996 | ‡2 NUKAT|n 2004092822 | ||
| 996 | ‡2 SUDOC|240984153 | ||
| 996 | ‡2 LC|n 2018069964 | ||
| 996 | ‡2 BNC|981060981122106706 | ||
| 996 | ‡2 BNE|XX6229235 | ||
| 996 | ‡2 NSK|000559391 | ||
| 996 | ‡2 DNB|1153781638 | ||
| 996 | ‡2 ISNI|0000000031363884 | ||
| 996 | ‡2 BNCHL|10000000000000000165653 | ||
| 996 | ‡2 BNE|XX1449970 | ||
| 996 | ‡2 BNE|XX949741 | ||
| 996 | ‡2 SUDOC|272573469 | ||
| 996 | ‡2 ISNI|0000000452289037 | ||
| 996 | ‡2 ISNI|0000000455271991 | ||
| 996 | ‡2 BNE|XX944656 | ||
| 996 | ‡2 LC|nr 91039397 | ||
| 996 | ‡2 LC|no2011191761 | ||
| 996 | ‡2 ISNI|0000000024232990 | ||
| 996 | ‡2 BAV|495_220735 | ||
| 996 | ‡2 ISNI|0000000118109088 | ||
| 996 | ‡2 J9U|987007338164505171 | ||
| 996 | ‡2 CAOONL|ncf11628124 | ||
| 996 | ‡2 BNE|XX5581981 | ||
| 996 | ‡2 PLWABN|9811523320805606 | ||
| 996 | ‡2 NII|DA01851885 | ||
| 996 | ‡2 BIBSYS|14010137 | ||
| 996 | ‡2 LC|no2011084033 | ||
| 996 | ‡2 SUDOC|134517768 | ||
| 996 | ‡2 BNE|XX1074477 | ||
| 996 | ‡2 ISNI|0000000061032031 | ||
| 996 | ‡2 LC|nb2022015098 | ||
| 996 | ‡2 SUDOC|14019536X | ||
| 996 | ‡2 BNE|XX1420431 | ||
| 996 | ‡2 BNE|XX907264 | ||
| 996 | ‡2 BNE|XX1744022 | ||
| 996 | ‡2 LC|n 2020048151 | ||
| 996 | ‡2 BNC|981060644763106706 | ||
| 996 | ‡2 SUDOC|148611923 | ||
| 996 | ‡2 BNE|XX1366354 | ||
| 996 | ‡2 LC|no2009126508 | ||
| 996 | ‡2 ISNI|0000000031351058 | ||
| 996 | ‡2 ISNI|0000000120314494 | ||
| 996 | ‡2 DNB|12392412X | ||
| 996 | ‡2 DNB|1057116661 | ||
| 996 | ‡2 LC|n 91074579 | ||
| 996 | ‡2 BNE|XX1238466 | ||
| 996 | ‡2 BAV|495_341938 | ||
| 996 | ‡2 DNB|1056404647 | ||
| 996 | ‡2 LC|no2015011726 | ||
| 996 | ‡2 ISNI|0000000059480193 | ||
| 996 | ‡2 DNB|1164603892 | ||
| 996 | ‡2 LC|no2011042437 | ||
| 996 | ‡2 ISNI|0000000079747262 | ||
| 996 | ‡2 LIH|LNB:C_g__s__h_;=CP | ||
| 996 | ‡2 DNB|172295556 | ||
| 996 | ‡2 BNE|XX1774290 | ||
| 996 | ‡2 NTA|304802034 | ||
| 996 | ‡2 NUKAT|n 2010145177 | ||
| 996 | ‡2 BNF|17891641 | ||
| 996 | ‡2 LC|no2011195617 | ||
| 996 | ‡2 ISNI|0000000384896715 | ||
| 996 | ‡2 DNB|1057182370 | ||
| 996 | ‡2 RERO|A013153288 | ||
| 996 | ‡2 NTA|071619267 | ||
| 996 | ‡2 ISNI|0000000059468098 | ||
| 996 | ‡2 BNCHL|10000000000000000116994 | ||
| 996 | ‡2 LC|ns2014001907 | ||
| 996 | ‡2 BNE|XX1632411 | ||
| 996 | ‡2 BNE|XX1399244 | ||
| 996 | ‡2 BNCHL|10000000000000000863307 | ||
| 996 | ‡2 LC|n 2011014807 | ||
| 996 | ‡2 BNE|XX4929234 | ||
| 996 | ‡2 LC|no2016070051 | ||
| 996 | ‡2 ISNI|0000000060438638 | ||
| 996 | ‡2 ISNI|0000000059523480 | ||
| 996 | ‡2 LIH|LNB:CEVX;=BS | ||
| 996 | ‡2 BNCHL|10000000000000000142055 | ||
| 996 | ‡2 LC|no2019168298 | ||
| 996 | ‡2 BNCHL|10000000000000000071167 | ||
| 996 | ‡2 BNF|11918220 | ||
| 996 | ‡2 RERO|A003659553 | ||
| 996 | ‡2 RERO|A003659550 | ||
| 996 | ‡2 BNE|XX5011890 | ||
| 996 | ‡2 BNC|981058609406006706 | ||
| 996 | ‡2 NII|DA19674451 | ||
| 996 | ‡2 BNE|XX1781893 | ||
| 996 | ‡2 ISNI|000000005130374X | ||
| 996 | ‡2 LC|n 2024009699 | ||
| 996 | ‡2 RERO|A013446971 | ||
| 996 | ‡2 RERO|A011719816 | ||
| 996 | ‡2 ISNI|0000000059514146 | ||
| 996 | ‡2 BNE|XX1220585 | ||
| 996 | ‡2 DBC|87097968789281 | ||
| 996 | ‡2 NUKAT|nx2024138988 | ||
| 996 | ‡2 LC|no2022138030 | ||
| 996 | ‡2 SUDOC|11774283X | ||
| 996 | ‡2 BNCHL|10000000000000000015298 | ||
| 996 | ‡2 ISNI|0000000115979918 | ||
| 996 | ‡2 SUDOC|070986541 | ||
| 996 | ‡2 DNB|105728890X | ||
| 996 | ‡2 SUDOC|242758738 | ||
| 996 | ‡2 BIBSYS|2137296 | ||
| 996 | ‡2 DNB|1156636892 | ||
| 996 | ‡2 NTA|166327670 | ||
| 996 | ‡2 ISNI|0000000463300203 | ||
| 996 | ‡2 LC|n 2018033483 | ||
| 996 | ‡2 J9U|987007338895405171 | ||
| 996 | ‡2 LC|n 93107526 | ||
| 996 | ‡2 BNC|981061033071306706 | ||
| 996 | ‡2 ISNI|0000000426001570 | ||
| 996 | ‡2 DNB|1056748834 | ||
| 996 | ‡2 LC|no2011154355 | ||
| 996 | ‡2 BNF|16274802 | ||
| 996 | ‡2 BNE|XX1625829 | ||
| 996 | ‡2 LC|no2010140553 | ||
| 996 | ‡2 DNB|1192480619 | ||
| 996 | ‡2 SUDOC|191244589 | ||
| 996 | ‡2 BNE|XX987044 | ||
| 996 | ‡2 BNE|XX879527 | ||
| 996 | ‡2 BNE|XX945478 | ||
| 996 | ‡2 ISNI|0000000357292369 | ||
| 996 | ‡2 BNCHL|10000000000000000240350 | ||
| 996 | ‡2 BNE|XX1602967 | ||
| 996 | ‡2 SUDOC|204078717 | ||
| 996 | ‡2 BNE|XX1004281 | ||
| 996 | ‡2 J9U|987007429700805171 | ||
| 996 | ‡2 LC|no2019098060 | ||
| 996 | ‡2 ISNI|0000000006552755 | ||
| 996 | ‡2 ISNI|0000000061016584 | ||
| 996 | ‡2 LC|ns2018003371 | ||
| 996 | ‡2 BNE|XX1160838 | ||
| 996 | ‡2 SZ|1194265944 | ||
| 996 | ‡2 BNE|XX1695447 | ||
| 996 | ‡2 DNB|1056195444 | ||
| 996 | ‡2 BNE|XX4581042 | ||
| 996 | ‡2 ISNI|0000000501443564 | ||
| 996 | ‡2 DNB|1220725404 | ||
| 996 | ‡2 RERO|A005666488 | ||
| 996 | ‡2 LC|nr 00003117 | ||
| 996 | ‡2 BNE|XX5172363 | ||
| 996 | ‡2 NUKAT|n 2011106785 | ||
| 996 | ‡2 DNB|171316959 | ||
| 996 | ‡2 BNE|XX5533910 | ||
| 996 | ‡2 DNB|1057621021 | ||
| 996 | ‡2 ISNI|0000000060263073 | ||
| 996 | ‡2 LC|n 2013005573 | ||
| 996 | ‡2 BNC|981058613795406706 | ||
| 996 | ‡2 BNF|16253466 | ||
| 996 | ‡2 SUDOC|088450783 | ||
| 996 | ‡2 ISNI|0000000370413559 | ||
| 996 | ‡2 LC|no2011099786 | ||
| 996 | ‡2 BIBSYS|90838145 | ||
| 996 | ‡2 BNCHL|10000000000000000100531 | ||
| 996 | ‡2 BIBSYS|15012783 | ||
| 996 | ‡2 ISNI|0000000118823644 | ||
| 996 | ‡2 BNE|XX955328 | ||
| 996 | ‡2 BNE|XX1007340 | ||
| 996 | ‡2 LC|n 2011184393 | ||
| 996 | ‡2 BNE|XX840705 | ||
| 996 | ‡2 LC|no2017079227 | ||
| 996 | ‡2 BNC|981058517744206706 | ||
| 996 | ‡2 LC|no2018034232 | ||
| 996 | ‡2 LC|ns2017001559 | ||
| 996 | ‡2 LNB|LNC10-000207989 | ||
| 996 | ‡2 BNE|XX4420373 | ||
| 996 | ‡2 BNE|XX1111689 | ||
| 996 | ‡2 J9U|987007272553905171 | ||
| 996 | ‡2 SUDOC|054058643 | ||
| 996 | ‡2 ISNI|000000006114392X | ||
| 996 | ‡2 DNB|1224571800 | ||
| 996 | ‡2 PLWABN|9810567929805606 | ||
| 996 | ‡2 DNB|131525506 | ||
| 996 | ‡2 LC|no2017127806 | ||
| 996 | ‡2 ISNI|0000000504145976 | ||
| 996 | ‡2 RERO|A011034692 | ||
| 996 | ‡2 NUKAT|n 94209243 | ||
| 996 | ‡2 J9U|987012502563905171 | ||
| 996 | ‡2 SUDOC|237775778 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
